Replies to post #14136 on Revive Therapeutics Ltd (RVVTF)

[Cool888]

If understand correctly, Revive must have repurposed Rimatil (Bucillamine),
If the clinical trial phase III of Bucillamine is successful, Chong Kun Dang (Santen Company), which has exclusive domestic sales rights, will obtain COVID-19 treatment indication. Guess, in EAST ASIA only.